| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6807
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6867
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-64 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-64 |
| filingDate |
2018-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ed7dbe413b09fe8075008b317ed1e64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6671454c66d7705015b31d13a962907f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d6cf29656bed87ce2aabe676b012962
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4aeb84c177ece0338e27e0a46ed4721
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bede39bd842631051cb880313429ae6f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_705636b4ae6780087a3541b08a26f114
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3961438e12f10f7feafda4e95c37ea9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1eea9aca5d87709a15e9c4b693da81e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_402873cc3237b3490fa42134f3cf4d58 |
| publicationDate |
2019-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MX-2019008773-A |
| titleOfInvention |
CALIQUEAMICIN DERIVATIVES AND ANTIBODY-DRUG CONJUGATES THEREOF. |
| abstract |
The present invention is directed to novel calicheamicin derivatives useful as drug antibody conjugates (ADC) in payloads and to payload linker compounds and ADC compounds comprising the same; to pharmaceutical compositions comprising the same and to methods of using the same to treat pathological conditions such as cancer. |
| priorityDate |
2017-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |